| Mrs Tara Danielle Capobianco, RN | |
|
153 Waterman Hill Rd, Coventry, RI 02827-1619 | |
| (401) 603-9975 | |
| Not Available |
| Full Name | Mrs Tara Danielle Capobianco |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Critical Care Medicine |
| Location | 153 Waterman Hill Rd, Coventry, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497473318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0200X | Registered Nurse - Critical Care Medicine | RN60114 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tara Danielle Capobianco, RN 153 Waterman Hill Rd, Coventry, RI 02827-1619 Ph: (401) 603-9975 | Mrs Tara Danielle Capobianco, RN 153 Waterman Hill Rd, Coventry, RI 02827-1619 Ph: (401) 603-9975 |
News Archive
Researchers have found that the budding yeast (Saccharomyces cerevisiae) is an acceptable model system to study KP1019, an anti-cancer drug that uses ruthenium, a rare metal, a new study found. Researchers had previously been interested in studying KP1019 because it is believed to cause cancer cell death and is not known to have negative secondary side effects for healthy tissues.
Biovail Corporation today commented on a proposed clinical trial recently announced by Teva Pharmaceutical Industries Ltd. According to Teva, the trial is intended to address reports of inefficacy and adverse events by consumers who switched from Wellbutrin XL® 300 mg, Biovail's FDA-approved brand of the antidepressant, bupropion hydrochloride, to Budeprion XL, Teva's generic formulation of the drug. The trial was described in a Dow Jones Newswire article dated December 2, 2009.
An international team of scientists led by a Cedars-Sinai researcher has identified a new genetic mutation that appears to protect people from developing Type 2 diabetes.
Newborns require special diagnosis and treatment considerations for an infectious diarrhea known as Clostridioides difficile infection, according to a new evidence-based white paper published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
TomoTherapy Incorporated announced today the availability of the industry's first relocatable radiation therapy solution - TomoMobile™ - which is designed to quickly and cost-effectively bring cutting-edge radiation therapy solutions to patients in underserved and rural markets.
› Verified 6 days ago
Mrs. Suzanne M Williams, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 85 Sandy Bottom Rd, Coventry, RI 02816 Phone: 401-821-0600 | |
Ms. Sharon Rapoza, RN, BSN, IBCLC, RLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 45 Taft St, Coventry, RI 02816 Phone: 401-338-2245 | |
Janice R Martin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 85 Sandy Bottom Rd, Coventry, RI 02816 Phone: 401-821-0600 | |
Taylor Dellagrotta, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 52 Cobblestone Ter, Coventry, RI 02816 Phone: 401-222-0944 | |
Emma P Vezikov, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 40 Ginger Trl, Coventry, RI 02816 Phone: 401-865-0003 | |
Samantha Falkowski, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4 Notre Dame St, Coventry, RI 02816 Phone: 401-487-1646 | |
Mary-elizabeth Lavoie, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 87 Rawlinson Dr, Coventry, RI 02816 Phone: 401-623-1725 |